Τίτλος:
Management of the elderly patients with high-grade serous ovarian cancer in the real-world setting
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older than 70 years of age. Methods: Medical records of women with high-grade serous ovarian cancer, stage III and IV were retrospectively analyzed. Results: A total of 735 patients were identified with a median age of 61.5 years. 22.4% among them were older than 70 years of age at diagnosis. First-line Progression-Free Survival (PFS) and Overall Survival (OS) were significantly worse in elderly patients in comparison to the younger ones [mPFS 11.3 months vs. 14.8 months, (p < 0.001) and mOS 30.2 months vs. 45.6 months (p < 0.001)]. However, elderly patients were characterized by worse ECOG-Performance Status and they were more frequently treated with Neoadjuvant Chemotherapy followed by Interval Debulking Surgery, while often they were more frequently denied debulking surgery compared to patients under 70 years of age. Moreover, elderly patients received more frequently monotherapy with platinum as frontline treatment. In contrast, there was no significant difference in the outcome of the debulking surgery in comparison to the younger patients or the frequency that gBRCA test was performed. Age over 70 years did not retain its significance for either Progression-Free Survival or Overall Survival when adjusted for all other reported prognostic factors. Conclusions: Elderly ovarian cancer patients have a worse prognosis. Comprehensive geriatric assessment should be performed for the optimal treatment of these patients. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Συγγραφείς:
Liontos, M.
Papatheodoridi, A.
Andrikopoulou, A.
Thomakos, N.
Haidopoulos, D.
Rodolakis, A.
Zagouri, F.
Bamias, A.
Dimopoulos, M.-A.
Περιοδικό:
Current Oncology
Λέξεις-κλειδιά:
bevacizumab; carboplatin; paclitaxel; platinum, adult; advanced cancer; aged; Article; cancer chemotherapy; cancer prognosis; cancer staging; cancer survival; clinical practice; cytoreductive surgery; disease exacerbation; ECOG Performance Status; electrocorticography; female; genetic screening; geriatric assessment; histology; human; major clinical study; monotherapy; neoadjuvant chemotherapy; ovary cancer; overall survival; prevalence; progression free survival; refraction error; retrospective study; risk factor; adjuvant chemotherapy; cytoreductive surgery; middle aged; ovary tumor, Aged; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies
DOI:
10.3390/curroncol28020110
